
Citinoct P 500mg/800mg Tablet
Marketer
Helen Pharmaceuticals Private Limited
Salt Composition
Citicoline (500mg) + Piracetam (800mg)
Overview Citinoct P 500mg/800mg Tablet
NeuroMend 500mg/800mg tablets aid in stroke recovery and cognitive function improvement. This medication safeguards brain cells from damage and promotes their repair, finding application also in brain injury treatment. NeuroMend may be administered with or without food, ideally at the same time daily for consistent blood levels. Follow your physician's prescribed dosage and schedule; if a dose is missed, take it immediately upon recall. Complete the entire course, even with symptom improvement, and never discontinue use abruptly without consulting your doctor, as this could exacerbate symptoms. Potential side effects, such as restlessness, abdominal discomfort, anxiety, and lowered blood pressure, are usually transient and self-limiting. Report persistent or bothersome side effects to your doctor. Maintain adequate hydration while using this medication, as diarrhea is possible. Weight gain may occur; manage this through a balanced diet and regular physical activity.
Primary Ingredients of Citinoct P 500mg/800mg Tablet
No text was provided to rewrite.
Uses of Citinoct P 500mg/800mg Tablet
Stroke Recovery and Rehabilitation
Major Benefits of Citinoct P 500mg/800mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Citinoct P 500mg/800mg Tablet whole; avoid crushing, chewing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Citinoct P 500mg/800mg Tablet:
- Weight gain
- Hyperactivity
- Stomach pain
- Nervousness
- Diarrhea
- Decreased blood pressure
- Uncoordinated body movements
- Dizziness
How to use Citinoct P 500mg/800mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Citinoct P 500mg/800mg Tablets can be administered with or without food, though consistent timing is recommended.
How Citinoct P 500mg/800mg Tablet works:
Citinoct P, a 500mg/800mg tablet, unites citicoline and piracetam to safeguard and enhance brain function. Citicoline, a neuroprotective agent, supports neuronal health by fostering cell nourishment, shielding against damage, and promoting cell viability. Piracetam, a GABAergic compound, offers neuroprotection against oxygen deprivation and modulates ion channel activity within neuronal membranes.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Citinoct P 500mg/800mg tablets is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Citinoct P 500mg/800mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Citinoct P 500mg/800mg tablets with breastfeeding are absent. Seek medical advice.
DrivingUNSAFE
Taking Citinoct P 500mg/800mg tablets may induce drowsiness or tremors, potentially impairing driving skills. These side effects could compromise your ability to operate a vehicle safely.
KidneyCAUTION
Patients with kidney impairment should use Citinoct P 500mg/800mg tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. Citinoct P 500mg/800mg tablets are unsuitable for individuals with severe kidney disease.
LiverSAFE IF PRESCRIBED
The use of Citinoct P 500mg/800mg tablets in patients with liver disease is likely safe. Existing evidence indicates dose modification may be unnecessary, but physician consultation is recommended.
What if you forget to take Citinoct P 500mg/800mg Tablet :
Should you forget to take a Citinoct P 500mg/800mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Citinoct P 500mg/800mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
